If you are willing, Mr. Chair, I'd like to continue this discussion.
In a few moments, we will be meeting the Vice Minister, Foreign Trade and Integration, from the Bolivian Ministry of Foreign Affairs. He spoke to us about the problems encountered by Biolyse Pharma in connection with the Canadian Access to Medicines Regime, and to technology transfer that would have made it possible to produce vaccines in Bolivia. The Canadian Access to Medicines Regime never really proved to be particularly effective, because after it was established, only one country, Rwanda in 2007, submitted an application, because the procedure was so complicated.
Why do you feel the system isn't working and why, as you have just explained, are we witnessing the same Canadian institutions organizing things in a way that makes sure they won't work?